1) Tirofiban
盐酸替罗非班
1.
Effect of Tirofiban on TIMI Flow in Patients with ST Segment Elevating of Treadmill Exercise Test;
盐酸替罗非班对活动平板运动试验ST段抬高患者TIMI血流分级的影响
2.
Clinical application of tirofiban in patients with acute coronary artery syndrome;
国产盐酸替罗非班治疗急性冠脉综合征的临床研究
3.
Effect of tirofiban on flow in patients with acute coronary syndrom during primary PCI;
盐酸替罗非班对急性冠脉综合征急诊经皮冠状动脉介入治疗中血流灌注的影响
2) Tirofiban hydrochloride
盐酸替罗非班
1.
Effect of tirofiban hydrochloride on myocardial microcirculation in patients after acute myocardial infarction;
盐酸替罗非班对心肌梗死患者微循环再灌注的影响
2.
The novel platelet GP Ⅱb/Ⅲa receptor antagonist——tirofiban hydrochloride;
新型血小板GPⅡb/Ⅲa受体拮抗剂盐酸替罗非班
3.
Effect of tirofiban hydrochloride on serum hs-CRP and matrix metalloproteinases-9 levles in patients with acute coronary syndrome;
盐酸替罗非班对急性冠脉综合征hs-CRP和MMP-9的影响
3) Tirofiban
替罗非班
1.
Investigation of the Efficacy and Safety of Tirofiban in Elderly Patients with Acute Coronary Syndromes Referred to Percutaneous Coronary Intervention;
替罗非班对老年急性冠脉综合征患者行PCI术的疗效及安全性分析
2.
Clinical investigation of Tirofiban in influence of percutaneous coronary intervention for complex coronary artery disease;
替罗非班对冠脉复杂病变介入治疗影响分析
3.
Effects of tirofiban on dose of heparin and platelet aggregation in patients with acute coronary artery syndrome;
替罗非班对急性冠状动脉综合征肝素剂量及血小板的影响
4) Home-produced Tirofiban
国产替罗非班
1.
Home-produced Tirofiban Influence on Clinical Symptoms of Patients with Acute Coronary Syndrome;
国产替罗非班对急性冠脉综合症患者临床症状的影响
6) Bambuterol hydrochloride
盐酸班布特罗
1.
Efficacy of fluticasome propinate combined with bambuterol hydrochloride in treatment of asthma in children;
丙酸氟替卡松联合盐酸班布特罗治疗儿童哮喘疗效观察
2.
Efficacy evaluation of oral liquid of bambuterol hydrochloride in treatment children with asthma;
盐酸班布特罗口服液治疗哮喘疗效观察
3.
Improvement of synthetic process for bambuterol hydrochloride;
盐酸班布特罗的合成工艺改进
补充资料：班加罗尔国际科技园
班加罗尔国际科技园
距市区21公里，占地68英亩。该园构想于1992年，由卡邦工业区发展委员会和[[新加坡]]国际财团合资建设，总投资4亿美元，其中新加坡占47%，印度塔塔集团占47%，卡纳塔克邦政府占6%。第一期工程占地5英亩，已经竣工。该园集办公、生产、居住和娱乐于一体，较好地满足国际高科技公司如信息技术、电子电讯、生化技术、金融服务等进驻的需要。投入使用后，已有90家公司入驻，其中包括我国的华为技术有限公司。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。